Saturday, 31 October 2026European Markets

HYDRATEC And ALAN ALLMAN Have A High Dividend Yield And Return On Equity In The Industrials Sector.

Loading stream...

(vianews) - hydratec (hydra.as) is among this list of stock assets with the highest dividend rate and return on equity on the industrials sector.

financial asset price forward dividend yield return on equity
hydratec (hydra.as) €143.00 4.23% 17.54%
alan allman (aaa.pa) €8.60 0.45% 23.5%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. hydratec (hydra.as)

4.23% forward dividend yield and 17.54% return on equity

hydratec industries nv, through its subsidiaries, manufactures and sells industrial systems and plastic components for food, health, and mobility markets in the netherlands, rest of europe, asia, north america, south america, africa, and oceania. it develops and produces sterilized product handling systems; and automated packaging solutions, including packaging for sterilized food in pouches, tins, and jars, as well as meal salads and agrifood in bags, nets, boxes, and crates. the company also supplies industrial incubators to produce day-old chicks; hatchery automation systems for processing of hatchery eggs and day-old chicks; climate control equipment for air and water treatment; hatchery management software for monitoring, analyzing, and optimizing of the incubation process; and service and support for hatchery systems operation. in addition, it manufactures extrusion equipment for pvc, pvc-o, and po pipes; plastic injection molding products for use in climate control systems, lorries, bicycle parts, and coffee machines; rubber, metal, and plastic precision components, that includes dosing systems, functional and safety parts for braking systems, and cartridges for diagnostics and other medical applications. hydratec industries nv is headquartered in amersfoort, the netherlands. hydratec industries nv operates as a subsidiary of hydra investments b.v.

earnings per share

as for profitability, hydratec has a trailing twelve months eps of €12.08.

pe ratio

hydratec has a trailing twelve months price to earnings ratio of 11.84. meaning, the purchaser of the share is investing €11.84 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 17.54%.

yearly top and bottom value

hydratec's stock is valued at €143.00 at 17:30 est, way below its 52-week low of €82.50.

volume

today's last reported volume for hydratec is 189 which is 69.11% below its average volume of 612.

more news about hydratec.

2. alan allman (aaa.pa)

0.45% forward dividend yield and 23.5% return on equity

alan allman associates, together with its subsidiaries, engages in the provision of consulting services in canada, france, belgium, luxembourg, switzerland, and singapore. the company offers technology consulting in the areas, including cybersecurity, cloud, data management, digitalization of tools and processes, etc.; strategy and management consulting comprising risk management, commercial intelligence, market finance, process management, change management, etc.; and industrial transformation consulting, such as purchasing and supply chain issues, relocation, cost reduction, project management, materials, process consulting, etc. the company was incorporated in 1954 and is based in issy-les-moulineaux, france.

earnings per share

as for profitability, alan allman has a trailing twelve months eps of €0.19.

pe ratio

alan allman has a trailing twelve months price to earnings ratio of 45.26. meaning, the purchaser of the share is investing €45.26 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 23.5%.

more news about alan allman.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com